Literature DB >> 6087824

Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates--in comparison with that of colchicine and various scavengers.

Y Niwa, T Sakane, Y Miyachi.   

Abstract

4,4'-Diaminodiphenyl sulfone (dapsone, DDS) is highly effective in dermatitis herpetiformis and immune complex disease in which polymorphonuclear leukocytes (PMN) play an important role. We studied the dose-response effect of DDS (10-1 mM) on the generation of oxygen intermediates (OI:O2-, H2O2, OH.) and chemiluminescence using PMN and the xanthine-xanthine oxidase system. The effect of colchicine and five oxygen radical scavengers on OI production in both systems was also examined and compared with that of DDS. We found that, except for O2- generation, which was slightly enhanced, DDS decreased the levels of OI measured as effectively as scavengers. Scavengers also capable of degrading OH. and 1O2 markedly reduced the levels of OH. and chemiluminescence while slightly increasing the level of O2-. Therefore, DDS was considered to exert effects similar to H2O2, and OH. and 1O2 scavengers. Colchicine did not decrease OI values produced in the xanthine-xanthine oxidase system but affected PMN-mediated OI generation, possibly by its cytoxic effect. Our results suggest that DDS, in contrast to colchicine brings about rapid clinical improvement in PMN-mediated autooxidative disorders by quenching reactive OI such as H2O2, OH. and chemiluminescence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087824     DOI: 10.1016/0006-2952(84)90705-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats.

Authors:  Camilo Ríos; Sandra Orozco-Suarez; Hermelinda Salgado-Ceballos; Marisela Mendez-Armenta; Concepción Nava-Ruiz; Iván Santander; Veronica Barón-Flores; Nadia Caram-Salas; Araceli Diaz-Ruiz
Journal:  Neurochem Res       Date:  2015-05-01       Impact factor: 3.996

2.  Dapsone in Henoch-Schönlein purpura--worth a trial.

Authors:  B I Hoffbrand
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

3.  Inhibitory effects of dapsone on enzymatic activities of membrane phospholipids in human blood cells.

Authors:  Y Niwa; Y Miyachi
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Antioxidant action of antimalarials.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

5.  Protective effect of 4,4'-diaminodiphenylsulfone against paraquat-induced mouse lung injury.

Authors:  Sung Chun Cho; Ji Heon Rhim; Hae Ri Choi; Young Hoon Son; Seok Jin Lee; Kye Yong Song; Sang Chul Park
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

6.  Luminol-independent chemiluminescence by phagocytes is markedly enhanced by dexamethasone, not by other glucocorticosteroids.

Authors:  Y Niwa; K Somiya; Y Miyachi; T Kanoh; T Sakane
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

7.  Experimental burn-induced changes in lipid peroxide levels, and activity of superoxide dismutase and glutathione peroxidase in skin lesions, serum, and liver of mice.

Authors:  S Kawai; J Komura; Y Asada; Y Niwa
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

8.  Kojic acid scavenges free radicals while potentiating leukocyte functions including free radical generation.

Authors:  Y Niwa; H Akamatsu
Journal:  Inflammation       Date:  1991-08       Impact factor: 4.092

9.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

10.  Oxygen metabolism in phagocytes of leprotic patients: enhanced endogenous superoxide dismutase activity and hydroxyl radical generation by clofazimine.

Authors:  Y Niwa; T Sakane; Y Miyachi; M Ozaki
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.